Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 2012

View Archived Issues

New inhibitors of V600E-mutant B-raf presented

Chugai presents new highly potent and selective AXL inhibitor

Pozen discusses FDA meeting on integrated aspirin therapy NDA

Bristol-Myers Squibb halts development of candidate hepatitis drug

JAK inhibitor reduces signs and symptoms of arthritis in phase III trials

Novel PET tracer for tau imaging shows promise in vivo

Zyclara approved in Europe

Updated results from EMILIA study of trastuzumab emtansine

Novartis reports new mTOR/PI3K inhibitors

Collaborating organizations in France design new candidate drugs for parasitic diseases

Novel beta1-adrenoceptor ligands developed in U.K.

FDA issues refuse to file letter for Lemtrada sBLA

New everolimus formulation approved in Japan

Data reported from TRILOGY ACS trial of prasugrel

Abbott presents discovery of multiple HCV NS5B inhibitors

Seattle Genetics kicks off new study in renal cell carcinoma

Ten-gene molecular signature predicts response to cancer radiotherapy

Baxter to discontinue manufacturing Gammagard product

Plavix approved for STEMI in Japan

Lilly reports topline phase III results in Alzheimer's disease

NICE issues draft guidance on product for stroke

GSK and Theravance complete phase III COPD program

Strattera approved in Japan for adult ADHD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...